BRKR Bruker Corporation
Healthcare$46.92+2.69%ClosedMarket Cap: $7.14B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
2.84
P/S
2.01
EV/EBITDA
26.77
DCF Value
$49.35
FCF Yield
0.7%
Div Yield
0.4%
Margins & Returns
Gross Margin
45.6%
Operating Margin
5.9%
Net Margin
-0.3%
ROE
-0.5%
ROA
-0.2%
ROIC
-2.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $823.4M | 47.3% | $45.0M | $14.4M | $— | $0.05 |
| Q4 null | $977.2M | 46.0% | $111.8M | $26.0M | $— | $0.05 |
| FY null | $3.44B | 45.9% | $236.0M | $-8.6M | $— | $0.20 |
| Q3 null | $860.5M | 44.1% | $35.0M | $-59.6M | $— | $0.05 |
| Q2 null | $797.4M | 44.9% | $11.9M | $7.6M | $— | $0.05 |
| Q1 null | $801.4M | 48.8% | $31.8M | $17.4M | $— | $0.05 |
| Q4 null | $979.6M | 50.4% | $72.1M | $13.7M | $— | $0.05 |
| FY null | $3.37B | 49.0% | $253.1M | $113.1M | $— | $0.20 |
| Q3 null | $864.4M | 48.4% | $68.1M | $40.9M | $— | $0.05 |
| Q2 null | $800.7M | 48.0% | $48.1M | $7.6M | $— | $0.05 |
| Q1 null | $721.7M | 48.9% | $64.8M | $50.9M | $— | $0.05 |
| Q4 2023 | $854.5M | 50.4% | $103.5M | $205.5M | $1.41 | $0.05 |